go to contents

a:head bio AG

Back to list

Facts

Founded
2019
Staff
9
Organization type
RDM biotech/pharma
Region
Vienna
Focus
human health

Profile

a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids

R&D:a:head’s drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini brains from human stem cells in vitro. They capture the essential aspects of human embryonic brain development including brain patterning, formation of brain ventricles, differentiation into the various neuronal and supportive cell types and their correct three-dimensional arrangement.

Similar companies in RDM biotech/pharma

F2G Biotech GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Focus
human health / animal health
Details

Qualizyme Diagnostics GmbH

Organization type
RDM biotech/pharma
Region
Styria
Cluster
Human.technology Styria
Focus
human health / animal health
Details

Evercyte GmbH

Organization type
RDM biotech/pharma
Region
Vienna
Cluster
LISAvienna
Focus
non-specific applications
Details

NP Life Science Technologies KG

Organization type
RDM biotech/pharma
Region
Upper Austria
Focus
non-specific applications
Details

Contact

Dr.-Bohr-Gasse 7, VBC6
1030 Wien
Vienna

Contact: Oliver Szolar (CEO)
Email: office@aheadbio.com
Website